Results 71 to 80 of about 191,956 (212)

EVALUATION OF RECOMBINANT AVIAN INFLUENZA COMPARED TO INACTIVATED VACCINES TO INDUCE IMMUNE RESPONSE IN CHICKEN [PDF]

open access: yesArab Universities Journal of Agricultural Sciences, 2018
The present Avian Influenza epidemic in Egypt is consider one of the major problems facing the poultry field and caused by circulation of genetically and antigenetically diverse influenza H5N1 viruses.
Dalia Omar, K. El-Dougdoug, B. Othman
doaj   +1 more source

Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2011
Factor H binding protein (fHbp) is an important antigen for vaccines against meningococcal serogroup B disease. The protein binds human factor H (fH), which enables the bacteria to resist serum bactericidal activity.
Rolando Pajon   +4 more
doaj   +1 more source

Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella [PDF]

open access: yes, 2017
Aiming to combine the flexibility of Brucella lumazine synthase (BLS) to adapt different protein domains in a decameric structure and the capacity of BLS and flagellin to enhance the immunogenicity of peptides that are linked to their structure, we ...
Berguer, Paula Mercedes   +11 more
core   +3 more sources

Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli

open access: yesVaccines, 2020
This article aims to review the present status of anti-flavivirus subunit vaccines, both those at the experimental stage and those already available for clinical use.
Sergio C. Araujo   +6 more
doaj   +1 more source

Current status of recombinant duck enteritis virus vector vaccine research

open access: yesFrontiers in Veterinary Science
Duck enteritis virus (DEV), the pathogen of duck viral enteritis, belongs to the α-herpesvirus subfamily. Like other herpesviruses, it has a large genome with multiple non-coding and non-essential regions for viral replication.
Wen-Feng Jia   +5 more
doaj   +1 more source

Adjuvants : an essential component of neisseria vaccines [PDF]

open access: yes, 2009
Adjuvants may be classified into delivery systems and immune potentiator or modulator molecules based on their mechanism of action. Neisseria vaccines containing traditional adjuvants such as aluminium salts have existed for long time, but meningitis ...
Acevedo, R.   +8 more
core  

In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae [PDF]

open access: yes, 2018
Actinobacillus pleuropneumoniae (A. pleuropneumoniae) is a Gram-negative bacterium that represents the main cause of porcine pleuropneumonia in pigs, causing significant economic losses to the livestock industry worldwide. A.
A Hensel   +55 more
core   +6 more sources

Long-lasting cross-protection against influenza A by neuraminidase and M2e-based immunization strategies [PDF]

open access: yes, 2016
There is mounting evidence that in the absence of neutralizing antibodies cross-reactive T cells provide protection against pandemic influenza viruses. Here, we compared protection and CD8+ T cell responses following challenge with H1N1 2009 pandemic and
Callewaert, Nico   +9 more
core   +2 more sources

Development of Streptococcus pneumoniae Vaccines Using Live Vectors

open access: yesVaccines, 2014
Streptococcus pneumoniae still causes severe morbidity and mortality worldwide, especially in young children and the elderly. Much effort has been dedicated to developing protein-based universal vaccines to conquer the current shortcomings of capsular ...
Shifeng Wang, Roy Curtiss III
doaj   +1 more source

Protective immunity against Trypanosoma cruzi [PDF]

open access: yes, 2009
Upon infection, Trypanosoma cruzi triggers a strong immune response that has both protective and pathological consequences. In this work, several important questions regarding protective immunity are reviewed.
Basombrío, Miguel Ángel Manuel   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy